4
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

Levonorgestrel for emergency contraception

&
Pages 565-576 | Published online: 10 Jan 2014

References

  • Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect. Sex. Reprod. Health38(2), 90–96 (2006).
  • Trussell J. Choosing a contraceptive: efficacy, safety, and personal considerations. In: Contraceptive Technology. (19th Edition) Hatcher RA, Trussell J, Nelson A, Cates W, Stewart FH, Kowal D (Eds.) Ardent Media, NY, USA, 19–47 (2007).
  • Trussell J, Stewart F, Guest F et al. Emergency contraceptive pills: a simple proposal to reduce unintended pregnancies. Fam. Plann. Perspect.24(6), 269–273 (1992).
  • Stewart F, Trussell J, Van Look PF. Emergency contraception. In: Contraceptive Technology, (19th Edition) Hatcher RA, Trussell J, Nelson A, Cates W, Stewart FH, Kowal D. (Eds.) Ardent Media, NY, USA, 87–116 (2007).
  • Glasier A. Emergency postcoital contraception. N. Engl. J. Med.337(15), 1058–1064 (1997).
  • Hatcher RA, Trussell J, Stewart FH, Howells S, Russell CR, Kowal D. Emergency Contraception: The Nation’s Best Kept Secret. Bridging the Gap Communications, GA, USA (1995).
  • Cheng L, Gulmezoglu AM, Oel CJet al. Interventions for emergency contraception (Review). Cochrane Database Syst. Rev.3, CD001324 (2004).
  • Ellertson C, Webb A, Blanchard K et al. Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial. Obstet. Gynecol.101(6), 1160–1167 (2003).
  • Hamoda H, Ashok PW, Stalder C et al. A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception. Obstet. Gynecol.104(6), 1307–1313 (2004).
  • Wu S, Wang C, Wang Y et al. A randomized, double-blind, multicenter study on comparing levonorgestrel and mifepristone for emergency contraception. J. Reprod. Med.8(Suppl. 1), 43–46 (1999).
  • von Hertzen H, Piaggio G, Ding J et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet360(9348), 1803–1810 (2002).
  • Creinin MD, Schlaff W, Archer DF et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet. Gynecol.108(5), 1089–1097 (2006).
  • Grimes DA. Intrauterine devices (IUDs). In: Contraceptive Technology. (19th Edition) Hatcher RA, Trussell J, Nelson A, Cates W, Stewart FH, Kowal D. (Eds) Ardent Media, NY, USA, 117–143 (2007).
  • Kook K, Gabelnick H, Duncan G. Pharmacokinetics of levonorgestrel 0.75 mg tablets. Contraception66(1), 73–76 (2002).
  • Raymond E. Contraceptive implants. In: Contraceptive Technology. (19th Edition). Hatcher RA, Trussell J, Nelson A, Cates W, Stewart FH, Kowal D. (Eds.) Ardent Media, NY, USA, 145–156 (2007).
  • Humpel M, Wendt H, Pommerenke G et al. Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women. Contraception17(3), 207–220 (1978).
  • Sambol NC, Harper C, Kim L et al. Pharmacokinetics of single-dose levonorgestrel in adolescents. Contraception74(2), 104–109 (2006).
  • Fotherby K. Variability of pharmacokinetic parameters for contraceptive steroids. J. Steroid Biochem.19(1C), 817–820 (1983).
  • Fotherby K. Levonorgestrel: clinical pharmacokinetics. Clin. Pharmacokinet.28(3), 203–215 (1995).
  • Hammond GL, Lahteenmaki PL, Lahteenmaki P et al. Distribution and percentages of non-protein bound contraceptive steroids in human serum. J. Steroid Biochem.17(4), 375–380 (1982).
  • Fotherby K. Pharmacokinetics of gestagens: some problems. Am. J. Obstet. Gynecol.163(1 Pt 2), 323–328 (1990).
  • Fotherby K. Pharmacokinetics and metabolism of progestins in humans. In: Pharmacology of the Contraceptive Steroids. Goldzieher J, Fotherby K, Lautenschlager M (Eds). Raven Press, NY, USA, 99–126 (1994).
  • Hapangama D, Glasier A, Baird DT. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle. Contraception63(3), 123–129 (2001).
  • Durand M, Cravioto MD, Raymond E et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception64(4), 227–234 (2001).
  • Marions L, Hultenby K, Lindell I et al. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet. Gynecol.100(1), 65–71 (2002).
  • Marions L, Cekan SZ, Bygdeman M et al. Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function. Contraception69(5), 373–377 (2004).
  • Croxatto HB, Brache V, Pavez M et al. Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation. Contraception70(6), 442–450 (2004).
  • Okewole IA, Arowojolu AO, Odusoga OL et al. Effect of single administration of levonorgestrel on the menstrual cycle. Contraception75(5), 372–377 (2007).
  • Durand M, Seppala M, Cravioto MDC et al. Late follicular phase administration of levonorgestrel as an emergency contraceptive changes the secretory pattern of glycodelin in serum and endometrium during the luteal phase of the menstrual cycle. Contraception71(6), 451–457 (2005).
  • Kesseru E, Garmendi F, Westphal N et al. Hormonal and peripheral effects of D-norgestrel in postcoital contraception. Contraception10(4), 411–424 (1974).
  • Croxatto HB, Devoto L, Durand M et al. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception63(3), 111–121 (2001).
  • Muller AL, Llados CM, Croxatto HB. Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat. Contraception67(5), 415–419 (2003).
  • Ortiz ME, Ortiz RE, Fuentes MA et al. Post-coital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkey cebus apella. Hum. Reprod.19(6), 1352–1356 (2004).
  • Novikova N, Weisberg E, Stanczyk FZ et al. Effectiveness of levonorgestrel emergency contraception given before or after ovulation – a pilot study. Contraception75(2), 112–118 (2007).
  • Piaggio G, von Hertzen H, Grimes DA et al. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation. Lancet353(9154), 721 (1999).
  • Davidoff F, Trussell J. Plan B and the politics of doubt. JAMA296(14), 1775–1778 (2006).
  • OPRR reports: protection of human subjects. Code of Federal Regulations 45CFR 46 (1983).
  • Hughes EC. Committee on Terminology, the American College of Obstetricians and Gynecologists. In: Obstetric–Gynecologic Terminology. FA Davis Company, PA, USA (1972).
  • Dixon GW, Schlesselman JJ, Ory HW et al. Ethinyl estradiol and conjugated estrogens as postcoital contraceptives. JAMA244(12), 1336–1339 (1980).
  • Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation – effects on the probability of conception, survival of the pregnancy, and sex of the baby. N. Engl. J. Med.333(23), 1517–1521 (1995).
  • Stirling A, Glasier A. Estimating the efficacy of emergency contraception – how reliable are the data? Contraception66(1), 19–22 (2002).
  • Espinos JJ, Rodriguez-Espinosa J, Senosiain R et al. The role of matching menstrual data with hormonal measurements in evaluating effectiveness of postcoital contraception. Contraception60(4), 243–247 (1999).
  • Espinos-Gomez JJ, Senosiain R, Mata A et al. What is the seminal exposition among women requiring emergency contraception? A prospective, observational comparative study. Eur. J. Obstet. Gynecol. Reprod. Biol.131(1), 57–60 (2007).
  • Raymond E, Taylor D, Trussell J et al. Minimum effectiveness of the levonorgestrel regimen of emergency contraception. Contraception69(1), 79–81 (2004).
  • Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. Contraception66(4), 269–273 (2002).
  • Ngai SW, Fan S, Li SQ et al. A randomized trial to compare 24h versus 12h double dose regimen of levonorgestrel for emergency contraception. Hum. Reprod.20(1), 307–311 (2005).
  • Ho PC, Kwan MSW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum. Reprod.8(3), 389–392 (1993).
  • Task Force on Post-Ovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet352(9126), 428–433 (1998).
  • Trussell J, Ellertson C, von Hertzen H et al. Estimating the effectiveness of emergency contraceptive pills. Contraception67(4), 259–265 (2003).
  • Ellertson C, Evans M, Ferden S et al. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstet. Gynecol.101(6), 1168–1171 (2003).
  • Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. Obstet. Gynecol.184(4), 531–537 (2001).
  • Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC guidance (April 2006). Emergency contraception. J. Fam. Plann. Reprod. Health Care32(2), 121–128 (2006).
  • Ellertson C, Trussell J, Stewart FH et al. Should emergency contraceptive pills be available without prescription? J. Am. Med. Womans Assoc.53(Suppl. 2), 226–232 (1998).
  • Grimes DA, Raymond E, Scott Jones B. Emergency contraception over-the-counter: the medical and legal imperatives. Obstet. Gynecol.98(1), 151–155 (2001).
  • Gold MA, Wolford JE, Smith KA et al. The effects of advance provision of emergency contraception on adolescent women’s sexual and contraceptive behaviors. J. Pediatr. Adolesc. Gynecol.17(2), 87–96 (2004).
  • Harper CC, Cheong M, Rocca CH et al. The effect of increased access to emergency contraception among young adolescents. Obstet. Gynecol.106(3), 483–491 (2005).
  • WHO. Medical Eligibility Criteria for Contraceptive Use. (2004).
  • Marston C, Meltzer H, Majeed A. Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys. Br. Med. J.331(7511), 271–273 (2005).
  • Moreau C, Bajos N, Trussell J. The impact of pharmacy access to emergency contraceptive pills in France. Contraception73(6), 602–608 (2006).
  • Glasier A, Baird D. The effects of self-administering emergency contraception. N. Engl. J. Med.339(1), 1–4 (1998).
  • Raine TR, Harper C, Leon K et al. Emergency contraception: advance provision in a young, high-risk clinic population. Obstet. Gynecol.96(1), 1–7 (2000).
  • Jackson RA, Schwarz EB, Freedman L et al. Advance supply of emergency contraception. Effect on use and usual contraception – a randomized trial. Obstet. Gynecol.102(1), 8–16 (2003).
  • Lo SS, Fan SY, Ho PC et al. Effect of advanced provision of emergency contraception on women’s contraceptive behaviour: a randomized controlled trial. Hum. Reprod.19(10), 2404–2410 (2004).
  • Raine TR, Harper C, Rocca CH et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA293(1), 54–62 (2005).
  • Hu X, Cheng L, Hua X et al. Advanced provision of emergency contraception to postnatal women in china makes no difference in abortion rates: a randomized controlled trial. Contraception72(2), 111–116 (2005).
  • Belzer M, Sanchez K, Olson J et al. Advance supply of emergency contraception: a randomized trial in adolescent mothers. J. Pediatr. Adolesc. Gynecol.18(5), 347–354 (2005).
  • Trussell J, Raymond E, Stewart FH. Re: advance supply of emergency contraception. J. Pediatr. Adolesc. Gynecol.19(3), 251 (2006).
  • Walsh TL, Frezieres RG. Patterns of emergency contraception use by age and ethnicity from a randomized trial comparing advance provision and information only. Contraception74(2), 110–117 (2006).
  • Raymond E, Stewart F, Weaver M et al. Impact of increased access to emergency contraceptive pills: a randomized controlled trial. Obstet. Gynecol.108(5), 1098–1106 (2006).
  • Polis CB, Schaffer K, Blanchard K et al. Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst. Rev.2 (2007).
  • Raymond E, Goldberg A, Trussell J et al. Bleeding patterns after use of levonorgestrel emergency contraceptive pills. Contraception73(4), 376–381 (2006).
  • Gainer E, Kenfack B, Mboudou E et al. Menstrual bleeding patterns following levonorgestrel emergency contraception. Contraception74(2), 118–124 (2006).
  • Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. FFPRHC guidance (April 2005). Drug interactions with hormonal contraception. J. Fam. Plann. Reprod. Health Care31(2), 139–151 (2005).
  • Guerts TBP, Goorissen EM, Sitsen JMA. Summary of Drug Interactions with Oral Contraceptives. Parthenon Publishing Group, Carnforth, UK (1993).
  • Wells ES, Hutchings J, Gardner JS et al. Using pharmacies in Washington State to expand access to emergency contraception. Fam. Plann. Perspect.30(6), 288–290 (1998).
  • Gardner JS, Hutchings J, Fuller TS et al. Increasing access to emergency contraception through community pharmacies: lessons from Washington State. Fam. Plann. Perspect.33(4), 172–175 (2001).
  • Marciante KD, Gardner JS, Veenstra DL et al. Modeling the cost and outcomes of pharmacist-prescribed emergency contraception. Am. J. Public Health91(9), 1443–1445 (2001).
  • Henshaw SK. Unintended pregnancy in the United States. Fam. Plann. Perspect.30(1), 24–29 (1998).
  • Trussell J, Raymond E. Preventing unintended pregnancy: let us count the ways. Lancet368(9549), 1747–1748 (2006).
  • Raymond E, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet. Gynecol.109(1), 181–188 (2007).
  • Glasier A, Fairhurst K, Wyke S et al. Advanced provision of emergency contraception does not reduce abortion rates. Contraception69(5), 361–366 (2004).
  • Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam. Plann. Perspect.31(6), 272–279 (1999).
  • Cantor J, Baum K. The limits of conscientious objection – may pharmacists refuse to fill prescriptions for emergency contraception? N. Engl. J. Med.351(19), 2008–2012 (2004).
  • Baergen R, Owens C. Revisiting pharmacists’ refusals to dispense emergency contraception. Obstet. Gynecol.108(5), 1277–1282 (2006).
  • Shacter HE, Gee RE, Long JA. Variation in availability of emergency contraception in pharmacies. Contraception75(3), 214–217 (2007).
  • Trussell J, Guthrie KA. Talking straight about emergency contraception. J. Fam. Plan. Reprod. H.33(3), 139–142 (2007).
  • Martinez B. Easier access to contraceptive may boost costs. WSJ. A (Eastern Edition)8 (2006).
  • Stewart FH, Trussell J. Prevention of pregnancy resulting from rape: a neglected preventive health measure. Am. J. Prev. Med.19(4), 228–229 (2000).
  • U.S. Department of Justice. A national protocol for sexual assault medical forensic examinations. NCJ 206554, 1–130 (2004).
  • Maze R. Emergency contraception still available. Marine Corps Times (2007).

Websites

  • Guttmacher Institute, NY, USA, 1999. www.guttmacher.org/pubs/ib_0599.html
  • The emergency contraceptive website www.not-2-late.com
  • Association of Reproductive Health Professionals. ARHP sign-on letter: switch status of emergency contraceptive from Rx to OTC. 2004. www.arhp.org/ec
  • International Consortium for Emergency Contraception, NY, USA, 2007 www.cecinfo.org/about/news.php#24
  • US Department of Defense, Washington DC, USA, 2007 www.pec.ha.osd.mil/BCF/bcfchange.htm
  • Princeton University, NJ, USA, 2007 http://ec.princeton.edu/news/phase-III.doc

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.